Approval · Notice of Compliance 8190 · 2006
UROMAX: Notice of Compliance 8190
Issued August 2, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8190
- Date
- August 2, 2006
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength 5 mg used for dose titration
- Therapeutic class
- Anticholinergic - antispasmodic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UROMAX | 02283646 | — |
Medicinal ingredients
- OXYBUTYNIN CHLORIDE 5 MG per TAB